The case for building slow
"Move fast and break things" was never good advice for healthcare. But somehow it became the default operating philosophy for the companies building inside it.
Health tech pitches are full of speed language. Ship faster. Scale quicker. Move from MVP to market before someone else does. The assumption is that speed is the primary competitive advantage, and anything that slows you down is waste.
In healthcare infrastructure, the opposite is true. Speed is not measured by how fast you ship. It is measured by how long what you ship holds.
A prescribing system built quickly with one clinic in mind will break the moment a second clinic, with different formularies and different care pathways, needs to run on the same architecture. A patient record structure designed around one consult type will fracture when it encounters the complexity of real clinical practice: chronic conditions, multi-provider coordination, medication interactions that span multiple prescribing events.
The teams that ship fastest are often the ones who rebuild the most. The architecture was optimised for launch speed, not operational durability. The speed was real. The foundation was not.
Building slow looks different. It means spending time on the data model before the interface. It means designing the prescribing layer to handle the second brand before the second brand exists. It means building the dispensing integration as infrastructure, not a feature bolted on when a partnership is signed.
None of this is visible to the market. Nobody announces "we spent three months on the data architecture." The companies that build slowly look, from the outside, like they are behind.
They are not behind. They are building load-bearing walls while others are hanging drywall.
A clinical guideline changes on a Tuesday. Prescribing rules for one brand need updating before the next morning's consults. In a system built on external tooling, that change enters a queue. A support ticket. A vendor sprint. The clinical team waits. In infrastructure built in-house, with the prescribing logic living where the clinical decisions live, the change ships the same day. That difference is invisible on an architecture diagram. It is only visible when you are the person fielding the call.
The fast company launches first. Gets traction. Then the second use case arrives and the architecture bends. Workarounds multiply. The slow company launches later. Then the second use case arrives and the architecture absorbs it. The third arrives and the platform holds. The speed advantage has inverted, because every change is a configuration, not a rebuild.
The ones that hold were built by teams who understood that in healthcare, the most expensive mistake is not being late to market. It is shipping infrastructure that cannot survive its second year.
Build slowly enough to build correctly. That is the only speed that matters.